Common Bioresearch Monitoring Violations: Updates from FY 20

The Bioresearch Monitoring Program (BIMO), run by the U.S. Food and Drug Administration (FDA), oversees the conduct of on-site inspections and data audits of FDA-regulated research in...

Related Keywords

, Bioresearch Monitoring Program , Drug Administration , Compliance Program Guidance Manuals , Fiscal Year , Warning Letters , Investigational New Drug , Warning Letter , Biologics License Application , Program Guidance Manuals ,